2025-09-25 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive (CL) based on the information you provided.

**Report on Colgate-Palmolive Co (CL)**

Colgate-Palmolive Co. is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and pet nutrition products.

**1. Performance vs. S&P 500 (VOO)**

*   **CL Cumulative Return:** 13.12%
*   **VOO Cumulative Return:** 69.58%
*   **Absolute Divergence (Current):** -56.46%  (CL underperformed VOO by this amount).
*   **Divergence Range:** Max 7.9, Min -99.3
*   **Relative Divergence:** 0.0 (meaning the current divergence is near its worst historical level within the provided data).

**Analysis:** CL has significantly underperformed the S&P 500 based on cumulative returns. The Relative Divergence indicates this underperformance is near the lowest point within the analyzed timeframe.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha   | Beta  | Cap(B) |
|------------|---------|---------|---------|-------|--------|
| 2015-2017  | 7.0%    | 58.3%   | -18.0%  | 0.1   | 61.0   |
| 2016-2018  | -7.0%   | 71.3%   | -25.0%  | 0.1   | 48.1   |
| 2017-2019  | 6.0%    | 71.3%   | -20.0%  | -0.7  | 55.6   |
| 2018-2020  | 8.0%    | 81.3%   | -3.0%   | -0.3  | 69.1   |
| 2019-2021  | 11.0%   | 81.3%   | -18.0%  | 0.5   | 69.0   |
| 2020-2022  | 5.0%    | 82.5%   | 10.0%   | 1.5   | 63.7   |
| 2021-2023  | 7.0%    | 82.5%   | -4.0%   | 0.8   | 64.4   |
| 2022-2024  | 23.0%   | 82.5%   | -1.0%   | 0.8   | 73.5   |
| 2023-2025  | 9.0%    | 99.3%   | -31.0%  | 0.6   | 65.6   |

*   **CAGR:** Compounded Annual Growth Rate varies significantly over the periods.
*   **MDD:** Maximum Drawdown is quite high across all periods, indicating substantial potential for loss.
*   **Alpha:** Mostly negative, indicating underperformance relative to its risk-adjusted benchmark.  Some periods show positive Alpha, but generally the trend is negative.
*   **Beta:** Generally low, suggesting CL is less volatile than the market.

**2. Recent Price Action**

*   **Current Price:** 81.15
*   **Previous Close:** 80.15
*   **Change:** 1.25
*   **5-day Moving Average:** 81.09
*   **20-day Moving Average:** 83.01
*   **60-day Moving Average:** 85.83

**Analysis:** The price is above the 5-day moving average but below both the 20-day and 60-day moving averages. This suggests a potential short-term upward trend, but the longer-term trend (20 and 60 day) is still downward. The price increase from previous close indicate a positive price movement on last market day.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.434 (Medium Risk)
*   **RSI:** 39.39 (Approaching oversold territory - typically below 30)
*   **PPO:** -0.29 (Negative, indicating a downward trend)
*   **Hybrid Signal:** Cash_0%_Buy 50% of cash (1 shares - Caution - MRI:0.40)
*   **Delta_Previous_Relative_Divergence (20-day):** 0.0 (Short-term decrease in relative performance)
*   **Expected Return (%):** -3703.9 (Very significantly negative, suggesting substantial underperformance versus S&P 500 in the long term)

**Analysis:** The RSI suggests the stock might be approaching oversold conditions.  The negative PPO confirms a downward trend.  The hybrid signal suggests caution and only partial buying.  The very negative expected return is a major concern, suggesting significant underperformance compared to the S&P 500 over the long term. The recent positive price movement, along with approaching oversold condition, might provide potential buying opportunity in near future.

**4. Recent News & Significant Events:**

*   **Dividend Stock Portfolio Strategy:**  Highlights CL's role as a dividend stock.
*   **Analyst Report (Morningstar):** General company analysis.
*   **RBC Trims Price Target:** Reduced target price to $96, but maintains a "Sector Perform" rating.
*   **Colgate-Palmolive (CL) is a Strong Growth Stock:** Positive article from Zacks.
*   **Colgate agrees to modify toothpaste packaging:** Minor regulatory/compliance news.

**Analysis:** The news is mixed.  The dividend focus and the "strong growth stock" article are positive.  However, the RBC price target trim and the packaging modification suggest some challenges.

**4-2) Analyst Opinions:**

*   **Consensus:** Buy (2.05 on a 1-5 scale)
*   **Opinions:** 18
*   **Target Price (avg/high/low):** 95.22 / 106.00 / 83.00

**Analysis:** Analyst consensus is generally positive ("Buy"), with a significant upside potential based on the average target price. However, the low target is almost same as current price.

**5. Recent Earnings Analysis:**

| 날짜         | EPS  | 매출     |
|--------------|------|----------|
| 2025-08-01   | 0.92 | 5.11 B$  |
| 2025-04-25   | 0.85 | 4.91 B$  |
| 2024-10-25   | 0.9  | 5.03 B$  |
| 2024-07-26   | 0.89 | 5.06 B$  |
| 2025-08-01   | 0.89 | 5.06 B$  |

**Analysis:**  Revenue and EPS have been relatively stable over the last few quarters.  The most recent quarter (2025-08-01) shows a slight increase in both EPS and revenue.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|----------------|
| 2025-06-30   | $5.11B    | 60.06%         |
| 2025-03-31   | $4.91B    | 60.82%         |
| 2024-12-31   | $4.95B    | 60.30%         |
| 2024-09-30   | $5.03B    | 61.08%         |
| 2024-06-30   | $5.06B    | 60.62%         |

**Capital and Profitability:**

| Quarter      | Equity    | ROE      |
|--------------|-----------|----------|
| 2025-06-30   | $0.70B    | 105.84%  |
| 2025-03-31   | $0.36B    | 190.08%  |
| 2024-12-31   | $0.21B    | 348.58%  |
| 2024-09-30   | $0.43B    | 169.43%  |
| 2024-06-30   | $0.12B    | 594.31%  |

**Analysis:**

*   **Revenue:** Relatively stable.
*   **Profit Margin:** Consistently high, indicating strong pricing power and cost management.
*   **Equity:** Fluctuating, increasing recently.
*   **ROE:** Extremely high, but also highly variable.  This suggests potential financial leverage or other factors significantly impacting returns on equity. It's important to investigate the reason for this high fluctuation of ROE.

**7. Overall Summary**

Colgate-Palmolive (CL) presents a mixed picture:

*   **Underperformance:**  Significantly underperforming the S&P 500. The technical indicators and relative divergence analysis also indicate negative price momentum.
*   **Financial Stability:** Relatively stable revenue, high profit margins.
*   **Analyst Sentiment:**  Generally positive with a "Buy" consensus and potential upside.
*   **Risk Factors:** High maximum drawdown, and concerns about long-term underperformance versus the S&P 500, and fluctuation of ROE.

**Conclusion:**

Based on the provided data, CL is not a strong buy. It might be reasonable investment consideration at the point that RSI indicator showing oversold condition with latest positive price movement, and the potential dividend income might be attractive to some investors. Further research is necessary to understand the drivers behind the negative expected return and high fluctuation of ROE.
